Trelagliptin succinate
Trelagliptin(SYR-472) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D).
| Catalog Number | T2296 |
| Alternative Name(s) | SYR-472 succinate , SYR472 |
| Research Area | Ubiquitination|||Proteases/Proteasome |
| Molecular Formula | C22H26FN5O6 |
| CAS# | 1029877-94-8 |
| SMILES | Cn1c(=O)cc(n(c1=O)Cc1c(ccc(c1)F)C#N)N1CCC[C@H](C1)N.C(CC(=O)O)C(=O)O |
| Size | 25 mg |
| Supplier Page | https://www.targetmol.com/compound/Trelagliptin succinate |
| Additional Information | https://www.targetmol.com/datasheet/T2296 |